Article Details

EPS for Akebia Therapeutics, Inc. (AKBA) Expected At $-0.37

Retrieved on: 2019-10-17 05:16:20

Tags for this article:

Click the tags to see associated articles and topics

EPS for Akebia Therapeutics, Inc. (AKBA) Expected At $-0.37. View article details on hiswai:

Excerpt

<div>The Pennsylvania-based Pnc Financial Services Gp Inc has invested 0% in Akebia Therapeutics, Inc. (NASDAQ:AKBA). <b>Baupost Group</b> Lc Ma holds ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up